Graft-versus-host disease treatment: predictors of survival (Q34205096)

31 July 2017

title

Graft-versus-host disease treatment: predictors of survival (English)

1 reference

31 July 2017

John E Levine

1

1 reference

31 July 2017

Brent Logan

2

1 reference

31 July 2017

Juan Wu

3

1 reference

31 July 2017

Amin M Alousi

4

1 reference

31 July 2017

Vincent Ho

5

1 reference

31 July 2017

Javier Bolaños-Meade

6

1 reference

31 July 2017

Daniel Weisdorf

7

1 reference

31 July 2017

Blood and Marrow Transplant Clinical Trials Network

8

1 reference

31 July 2017

publication date

9 June 2010

1 reference

Biology of Blood and Marrow Transplantation

31 July 2017

published in

1 reference

31 July 2017

volume

16

1 reference

31 July 2017

issue

12

1 reference

31 July 2017

page(s)

1693-1699

1 reference

Elafin is a biomarker of graft-versus-host disease of the skin

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955996

Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955996

A biomarker panel for acute graft-versus-host disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955996

Impact of graft-versus-host disease on survival

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955996

An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955996

Prophylaxis and treatment of acute graft-versus-host disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955996

Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955996

Novel approaches to the therapy of steroid-resistant acute graft-versus-host disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955996

Diagnosis and clinical management of chronic graft-versus-host disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955996

Fungal infections after bone marrow transplant

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955996

The best endpoint for acute GVHD treatment trials

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955996

Prophylaxis regimens for GVHD: systematic review and meta-analysis

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955996

Study design and endpoints in graft-versus-host disease

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955996

Chronic graft-versus-host disease

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955996

Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2955996

Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20541024

12 December 2020

inferred from PubMed ID database lookup

Graft-versus-host disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20541024

12 December 2020

inferred from PubMed ID database lookup

Increase in FOXP3+ Regulatory T Cells in GVHD Skin Biopsies Is Associated with Lower Disease Severity and Treatment Response

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20541024

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1016/J.BBMT.2010.05.019

1 reference

release_7r4gwk3ufvduva3pmmh6nqkts4

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7r4gwk3ufvduva3pmmh6nqkts4

24 November 2022

mapped directly with Wikidata item

PMC publication ID

2955996

1 reference

31 July 2017

1 reference